Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien launches next-generation stent in Europe

This article was originally published in Clinica

Executive Summary

Covidien has launched its EverFlex+ self-expanding peripheral stent in Europe. The device is a next-generation version of the EverFlex stent, originally developed by ev3, which was launched worldwide in 2006 for peripheral arterial disease and stenting of the superficial femoral artery. Covidien agreed to buy ev3 in June (www.clinica.co.uk, 2 June 2010), and the purchase was completed in July. EverFlex+, which was CE marked in October 2010, has been designed to lower the risk of fracture when elongated, thereby improving clinical outcomes. It has similar radial strength and flexibility as the older device, but greater durability, Dublin, Ireland-based Covidien claims. EverFlex+ is not currently available in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel